Publication | Closed Access
Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
15
Citations
0
References
1974
Year
Hydrocortisone HemisuccinateNeurological DisorderPharmacologyClinical TrialsNeurological ProgressNeurologyMultiple SclerosisNeuropathologyMedicineTherapeutic Trial
No additional data available for this publication yet. Check back later!